TROY BOOVY: Open Payments
NPI 1215055637 · SALISBURY, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,658 in 73 payments from 10 companies in 2025. Trend: 2023 $953 · 2024 $808 · 2025 $1,658
Food & beverage: $1,519Education: $139
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 18 | $439 |
| Neurocrine BioSciences, Inc. | 15 | $331 |
| Teva Pharmaceuticals USA, Inc. | 6 | $217 |
| Alkermes, Inc. | 9 | $188 |
| Otsuka America Pharmaceutical, Inc. | 8 | $162 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $152 |
| Janssen Pharmaceuticals, Inc | 5 | $96 |
| ABBVIE INC. | 2 | $36 |
| Axsome Therapeutics, Inc. | 1 | $22 |
| Vanda Pharmaceuticals Inc. | 1 | $16 |
Products named: COBENFY, INGREZZA, ARISTADA, ABILIFY ASIMTUFII, CAPLYTA, UZEDY, INVEGA SUSTENNA, VRAYLAR.
Industry payments across NC — which companies pay providers there.
